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Abstract
Introduction: The aim of this study was to examine health-related quality of life (HRQoL) as measured by EQ-5D and to
investigate the influence of chronic conditions and other risk factors on HRQoL based on a distributed sample located in
Shaanxi Province, China.
Methods: A multi-stage stratified cluster sampling method was performed to select subjects. EQ-5D was employed to
measure the HRQoL. The likelihood that individuals with selected chronic diseases would report any problem in the EQ-5D
dimensions was calculated and tested relative to that of each of the two reference groups. Multivariable linear regression
models were used to investigate factors associated with EQ VAS.
Results: The most frequently reported problems involved pain/discomfort (8.8%) and anxiety/depression (7.6%). Nearly half
of the respondents who reported problems in any of the five dimensions were chronic patients. Higher EQ VAS scores were
associated with the male gender, higher level of education, employment, younger age, an urban area of residence, access to
free medical service and higher levels of physical activity. Except for anemia, all the selected chronic diseases were indicative
of a negative EQ VAS score. The three leading risk factors were cerebrovascular disease, cancer and mental disease.
Increases in age, number of chronic conditions and frequency of physical activity were found to have a gradient effect.
Conclusion: The results of the present work add to the volume of knowledge regarding population health status in this
area, apart from the known health status using mortality and morbidity data. Medical, policy, social and individual attention
should be given to the management of chronic diseases and improvement of HRQoL. Longitudinal studies must be
performed to monitor changes in HRQoL and to permit evaluation of the outcomes of chronic disease intervention
programs.
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Introduction
Chronic diseases are the leading health challenges of the 21st
century. The World Health Organization (WHO) reported that,
out of 36 million deaths that occurred in 2008, almost two thirds
were due to chronic conditions, such as cardio-cerebral-vascular
disease, hypertension, chronic respiratory disease, and diabetes.
Nearly 80% of these deaths occurred in middle- and low-income
countries, populations and communities [1–3]. Chronic diseases
have become a major public health problem in China, where
nearly 260 million chronic disease cases have recently been
diagnosed. Along with the accelerating process of industrialization,
urbanization and aging, China’s health system will face multiple
challenges from the increasing prevalence of chronic disease and
mortality rates and from the increasing incidence of these
conditions among younger and lower-income individuals [4–9].
Shaanxi is a middle-income province located in Northwestern
China. The 2008 National Health Service Survey (NHSS) of
Shaanxi Province reported that more than 6.7 million individuals,
about 17.5% of the total population, had been diagnosed with
chronic conditions. The incidences of many chronic diseases have
increased rapidly since 2003. For example, the number of people
with hypertension, diabetes, and cardio-cerebral-vascular diseases
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has been found to be 1.3, 1 and .30 times greater than that in
2003, respectively [10].
Chronic diseases not only pose a heavy economic burden on the
individual, family, and society, but also seriously affect patients’
quality of life. Studies performed during the past few decades have
indicated that health-related quality of life (HRQoL), which refers
to physical, psychological, and social functioning as reported by
the patients themselves, has become an important component of
chronic disease evaluation and monitoring in addition to
conventional objective indicators, such as morbidity, mortality
and clinical measurements [11–14]. The questionnaires, including
the EuroQol questionnaire (EQ-5D), SF-36, SF-12, the Health
Utilities Index (HUI) and other measurement systems, have been
used in large surveys to measure HRQoL in both general and
specific populations [15–18].
Because of the ease with which it can be administered, scored,
and interpreted, EQ-5D has gained widespread popularity,
especially in large-scale face-to-face health surveys conducted by
interview. It also imposes a minimal burden on the respondents
because it is brief and easy for most people to understand and to
complete [15,19–21]. The EQ-5D consists of five dimensions,
mobility, self-care, usual activities, pain/discomfort, and anxiety/
depression. Each dimension has three levels of response or severity
(no problems, some problems and extreme problems). The ability
to convert the self-classifications into a single index score makes
the EQ-5D practical for both clinical and economic evaluations
[15]. Unfortunately, there is no locally appropriate standard for
calculation of the index. In addition to those five dimensions, the
visual analog scale (VAS) component of the last part of the EQ-5D
allows respondents to place their current health status on a range
from 0 (worst imaginable health status) to 100 (best imaginable
health status). EQ-5D population health studies have been
performed in Europe, the U.S., Canada and Asia (including
China) [22,23]. Previous studies performed in mainland China
and on other Chinese populations abroad have demonstrated the
applicability of EQ-5D in measuring health status in Chinese
populations [23–26]. Most previous studies have suggested that the
EQ-5D is not only useful for evaluating general populations, but
also applicable to various chronic diseases such as cardiovascular
diseases [27], chronic heart failure [28], chronic kidney disease
[29], chronic obstructive pulmonary disease [30], musculoskeletal
diseases [31] and type 2 diabetes [32,33]. In 2008, the EQ-5D was
included in the NHSS for the first time in order to assess
population health status in 31 provinces in mainland China.
Shaanxi Province was included as a western extended sample in
the 2008 NHSS.
Most EQ-5D studies performed on Chinese populations with
chronic conditions have focused on one specific disease. Few have
compared the impacts of different chronic diseases at the
population level. In this study, the population of Shaanxi was
profiled to establish a baseline for future evaluation and
surveillance. The EQ-5D results were then evaluated among
general patients, healthy individuals, individuals with chronic
diseases and individuals with co-morbidities and the non-chronic
groups were compared to those with 13 specific chronic diseases.
The effects on VAS from each chronic disease and the number of
chronic conditions, excluding multiple confounding effects, were
evaluated.
Methods
National Health Service Survey
Data were collected from the Shaanxi’s fourth NHSS. The
NHSS is organized by the Ministry of Health (MOH) of China
and it has been conducted every five years since 1993. An
introduction to perform face-to-face interviews for the National
Health Service Survey was provided by the MOH. The
interviewers were recruited from populations of local health
workers and trained by supervisors who were recruited from local
health authority staff and trained at the national level. In addition,
nine western provinces also use the multi-stage stratified cluster
sampling method to select provincially representative samples. We
adopted the NHSS form with the same questionnaire, survey and
quality control methods and conducted the survey at the same
time of the same year as the national level [34]. The questionnaire
used for the NHSS in 2008 included more than 200 questions.
These were related to the areas of acute diseases and injuries,
chronic and other diseases, hospitalizations, health-related behav-
iors, educational level, family income and employment status,
social relations, safety and security, medical care fees, accessibility
of medical care (distance and time), level of satisfaction with health
services, insurance coverage, vaccination and disease control, and
health services specific to women and children. The EQ-5D was
placed at the beginning of the questionnaire, after the sections with
questions on general information and diseases and injuries, but
before questions regarding health-related behavior. This was the
first time that the NHSS included EQ-5D, which was useful in
establishing an HRQoL baseline for the Chinese population at the
national level.
In Shaanxi’s NHSS 2008, the estimated sample size was 13600
according to the NHSS sample rate (1/5000), population size of
Shaanxi Province (40 million) and design effect (1.7). In the first
stage, to ensure the sample representativeness in the terms of
demographic, socioeconomic and health status indicators, 40 out
of 107 primary sample units (districts in urban areas and counties
in rural areas) were randomly selected. In the second stage, 2 sub-
districts (known as jiedao in Chinese) within districts and
townships (known as xiang and zhen, respectively, in Chinese)
were randomly selected from each of the first-stage samples. In the
third stage, 2 residential committees (known as juweihui in
Chinese) in the sub-districts or villages (known as cun in Chinese)
of townships were randomly selected from each of the second-stage
samples. If the population of the jiedao was very large, sometimes
3 or 4 committees would be selected. In each residential
committee and village, 35 households were randomly selected
and all family members in each sampled household were
interviewed individually. EQ-5D was then reported. If participants
had the ability to answer the questions in writing, they personally
filled out the forms, following the instructions; otherwise a trained
interviewer would collect the necessary data from respondents
through face-to-face interviews.
Classification of chronic conditions
The chronic conditions were self-reported and the interviewers
had to make sure the chronic conditions were clinically diagnosed
in order to reduce mistake due to self-reporting. The diagnoses
and morbidity data were coded according to ICD-10 and the
disease classification of the fourth NHSS [34]. Thirteen chronic
diseases were extracted from the codes on the basis of both
prevalence and disease burden: infectious diseases, cancer,
diabetes, anemia, mental disease, heart disease, hypertension,
cerebrovascular disease, respiratory disease (mainly chronic
pharyngitis, pulmonary emphysema, chronic obstructive pulmo-
nary disease, and asthma), digestive diseases (mainly anxious
chronic gastroenteritis, peptic ulcers, gallstones, and cholecystitis),
genitourinary disease (mainly nephritis, prostatic hyperplasia, and
breast diseases), musculoskeletal disease (mainly rheumatoid
arthritis, lumbar intervertebral disk diseases, and other musculo-
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skeletal diseases), and other chronic diseases. Conditions were
numbered based on the first reported chronic condition, which
was considered the most important one as defined by the NHSS
questionnaire.
Classification of population
Based on the answers to the following two questions, ‘‘Have you
suffered from any chronic diseases during the last half a year?’’ and
‘‘Have you experienced any discomfort during the two weeks
immediately before the survey?’’, we divided the respondents into
four categories: people with chronic conditions who had experi-
enced discomfort during the two weeks immediately before the
survey, people with chronic conditions who did not experience any
discomfort during the two weeks immediately before the survey,
people without chronic conditions who experienced discomfort
during the two weeks immediately before the survey, and people
without chronic conditions who did not experience any discomfort
during the two weeks immediately before the survey. The first two
categories were then defined as our research population group
(chronic disease group), and the third category was classified as the
general patients group, and the fourth category as the healthy
group. The third and fourth groups were used as reference groups.
Statistical analysis
For convenience, certain parts of the socio-demographic
variables were reclassified. For example, age was divided into
three groups, (specifically 15–44, 45–64, and 65+), educational
level was divided into two groups (below high school level and high
school level and above), and the frequency of weekly exercise was
divided into three levels (never, 1–6 times per week, more than 6
times per week). EQ-5D has ceiling effects in measuring the
general population, thus we transformed the three categories of
original responses in the EQ-5D self-classifier (no problem, some/
moderate problems, and extreme problems/unable to) into two
categories (reporting no problem and reporting any problem) [17].
Socio-demographic characteristics were examined. EQ-5D
results were also obtained for different groups, such as the four
groups defined in the classification of population section. The
relative risk of individuals with specific chronic diseases reporting
any problem against the two reference groups was analyzed based
on the Chi-square test and odds ratios (ORs) and 95% confidence
intervals (95% CIs) were obtained.
The independent effects of different chronic diseases, the
number of chronic conditions per participant, socio-demographic
variables, and health-related behavior variables were analyzed by
constructing two multivariable linear regression models. The EQ
VAS score served as the dependent variable for both models. In
the first model, different chronic diseases, socio-demographic
variables, and health-related behavior variables served as inde-
pendent variables. In the second model, the number of chronic
conditions, socio-demographic variables, and health-related be-
havior served as independent variables. All statistical analyses were
implemented using SAS 9.1 for Windows, considering the
complex sampling features with setting city as stratum and county
as cluster.
Ethical statements
The NHSS 2008 was approved by the National Bureau of
Statistics (license number: 2008 (18)). The NHSS is implemented
by the MOH every five years and the MOH has pledged to protect
the privacy of respondents and to facilitate the anonymous analysis
of the data according to article 14 of the third chapter of the
Statistics Law of the People’s Republic of China. For these
reasons, written consent was not required. The investigators read
the informed consent statement written on the second page of the
questionnaire and verbally asked for the interviewees’ permission.
Once the interviewees or their caregivers or guardians (in the case
of children) had verbally consented to participate in this study, the
investigators would sign their own names at the beginning of the
questionnaire.
Results
Out of 13,014 respondents examined in the Shaanxi’s NHSS in
2008, 1,840 were younger than 15 years old, 134 did not report in
any of the five dimensions, and 53 did not answer the question
‘‘Have you experienced any discomfort during the two weeks
immediately before the survey?’’ These respondents were exclud-
ed. Among those remaining, the rate of missing information was
lower than 2%. A total of 10,987 respondents were included in the
univariate analysis and 10,267 were included in the multivariable
linear models.
The socio-demographic and health-related characteristics of
research subgroups are shown in Table 1. The prevalence of
chronic diseases among respondents over the age of 15 was
16.73%, 19% of whom lived with two or more chronic conditions
simultaneously. The five most prevalent chronic diseases in
Shaanxi Province were hypertension, musculoskeletal disease,
digestive disease, heart disease, and respiratory disease. Diabetes is
the cause of many other chronic diseases, the prevalence of which
was also high in this study. The chronic disease groups were more
likely to include older people, women, people with less education,
people with lower employment rates, and people who were less
active. Chronic diseases, other than hypertension, heart disease,
and diabetes, were also associated with rural residents.
As shown in Figure 1, 5.6%, 3.6%, 5.3%, 8.8%, and 7.6% of
the respondents reported problems in the mobility, self-care, usual
activities, pain/discomfort, and anxiety/depression dimensions of
the EQ-5D, respectively. Overall, self-care dimension had the
lowest association with reporting any problem, however it was
most likely to be associated with reporting extreme problems
(1.1%). As shown in Table 2, the relative number of chronic
diseases among respondents who reported any problem in the
dimensions of EQ-5D approached 50%, which indicated that the
effects of chronic diseases on HRQoL, among residents of
Shaanxi, are very serious.
Table 3. shows the EQ-5D and EQ VAS scores of the four
groups and lists the recalculated results of EQ-5D and EQ VAS
scores of NHSS 2008. Results indicated that the likelihood of
reporting any problem in any of the five dimensions was greatest
among respondents with chronic diseases and detectable health
problems during the two weeks immediately before the survey,
followed by those with chronic diseases but no health problems
during the two weeks immediately before the survey, then general
patients, and lastly healthy people. The only exception was in the
anxiety/ depression dimension, in which the general patient group
was a little more likely to report problems than individuals with
chronic diseases who had no reported health problems during the
two weeks immediately prior to the survey (21.3% vs. 19.3%,
respectively). However, this was not true for EQ VAS. Table 4
shows the results of EQ-5D and EQ VAS among respondents with
different numbers of chronic conditions. The effects on the
HRQoL increased as the number of chronic conditions increased.
Table 5. shows the odds ratios among individuals with
chronic diseases to report problems compared with each of the
two reference groups. Individuals with chronic diseases were
significantly more likely to report any problem in EQ-5D than
healthy individuals. Cancer, mental disease, heart disease,
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cerebrovascular disease, musculoskeletal disease, and the other
chronic diseases were found to have significant effects in all of the
five dimensions when compared to participating patients lacking
these conditions. Some chronic diseases showed statistically
significant associations with certain dimensions, such as anemia
with A/P, hypertension and genitourinary disease with MO, and
respiratory disease with UA and A/P. Among the 13 chronic
diseases, cerebrovascular disease, cancer, and mental disease were
the three conditions with the greatest odds ratios in all five
dimensions when compared to both reference groups.
The results of multivariate linear regression models for EQ VAS
are shown in Table 6. Both model I and model II accounted for
about 30 percent of the total variance. The collinearity effects were
small and could be ignored. Model I indicated that all of the
selected chronic diseases, except anemia, were significant risk
predictors for the EQ VAS score. In model II, gradient increasing
effects were also observed in the chronic condition number
(b=26.52 for one condition, b=29.89 for two conditions, and
b=210.58 for three or more conditions). These factors were not
found to have significant effects in the general patient group
(b=0.66, P=0.7027). As shown in Table 6, the results of both
model I and model II indicated that residence in an urban area,
male gender, more education, young age, and more physical
activity were predictive of higher EQ VAS scores. Gradient
increasing effects were found to be statistically significantly
associated with age and physical activity, which meant that the
HRQoL decreased with increasing age and increased with higher
frequency of physical activity. Widowed individuals were more
likely to report lower EQ VAS scores than those currently married
and singles were likely to report higher HRQoL scores.
Employment was associated with a higher EQ VAS score. Free
medical service was associated with better HRQoL scores.
Smoking and alcohol use were not found to be associated with
significant negative effects.
Discussion
EQ-5D has been used in many studies to measure the HRQoL
among individuals with chronic diseases. The underlying results of
these previous studies have demonstrated that chronic disease is an
important risk factor for low HRQoL [22]. In the current study,
the associations between the chronic conditions and socio-
demographic and self-perceived health that were measured using
the EQ-5D were evaluated and a health-status baseline was
established at the population level in Shaanxi Province. This was
done to create a normative database for use as a reference when
conducting further studies regarding HRQoL, in populations with
chronic disease, in this region.
Figure 1. Distribution of the EQ-5D self-classified health states of the general population of Shaanxi Province, China.
doi:10.1371/journal.pone.0065958.g001
Table 2. Proportions of population with and without chronic
conditions among those who reported any problem in either
dimension of EQ-5D.
Chronic disease No chronic disease
EQ-5D Number Percentage Number Percentage
mobility 347 56.8 264 43.2
self-care 235 60.6 153 39.4
usual activities 339 58.5 240 41.5
pain and discomfort 550 56.6 422 43.4
anxiety and depression 406 49.0 423 51.0
doi:10.1371/journal.pone.0065958.t002
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The results indicated that nearly half of the respondents who
reported any problem in the dimensions of EQ-5D had lived with
clinically diagnosed chronic conditions at some point in their lives.
This suggests that chronic diseases are becoming some of the
leading risk factors for health status in Shaanxi Province. The EQ-
5D and EQ VAS score results were similar to those of the national
and western populations in the NHSS 2008. Pain/discomfort and
anxiety/depression were the two most frequently reported
dimensions with some or extreme problems, which was what
was found in the NHSS 2008 as well. All participants with chronic
conditions were significantly more likely to report any problem in
the dimensions of EQ-5D than healthy individuals. Individuals
with chronic diseases, including mental disease, cerebrovascular
disease, cancer, and heart disease, were significantly more likely to
report any problem than patients with non-chronic conditions.
This held true across all five dimensions. These chronic diseases
involve serious impairments at the individual level, even though
they are not the most prevalent chronic diseases [26,35]. For
example, mental disease is less prevalent than physical diseases are,
but it was found to be significantly more closely associated with
reports of other problems in all of the dimensions when compared
with the two reference groups. The negative effects of mental
disease on EQ VAS were the largest (coefficient =228.03,
P,0.0001). Therefore, impairments that each chronic condition
has on health at population level, as well as the individual level,
should be considered. Mental disease is often difficult to detect and
diagnose due to the delicacy of the issue in Chinese culture
[36,37]. For this reason, the prevalence and the level of
impairment brought on by mental disease may have been
underestimated in this study.
Results showed that, with the exception of anemia, all of the
chronic diseases evaluated in this study were risk factors for low
EQ VAS scores. Statistically significant factors involving socio-
demographic and health behavior variables included age, educa-
tion level, marital status, location of residence, employment status,
and frequency of physical activity. In a previous studied, Pappa
suggested that medical insurance had a significant protective effect
on health [14]. However, in our study, we did not find that the
Urban Residents’ Medical Insurance and/or the New Rural
Cooperative Medical System, which are the main providers of
social health insurance in China, had any positive effects on the
EQ VAS scores. This indicates that the health service provided by
the current main social medical insurance providers should be
further extended and improved. The protective effect of free
medical service was statistically significant. However, this insur-
ance plan covers only certain people in China, most of whom are
government officers, and these people consume a great deal of
health resources freely. This is indicative of inequality in health
insurance policy [38,39]. Smoking and alcohol use had no
significant negative effects on the EQ VAS score, and this may
have been due to measurement bias and sampling errors.
In this study, results indicated that older people are vulnerable
to more than one chronic condition and co-morbidity of chronic
diseases can have an even more serious impact on HRQoL. China
is an aging country [40–42]. Therefore, it is essential for China to
explore the aging process and the effects of combinations of
Table 3. Proportions of reporting any problem in EQ-5D and EQ VAS among the four groups.
Total Groups NHSS 2008 [23].
Group 1 Group 2 Group 3 Group 4 P-value Total Western
EQ-5D
mobility 5.6 23 14.8 10.4 2.3 ,0.0001 5.2 4.8
self-care 3.6 17.2 8.6 6.9 1.3 ,0.0001 3.3 3
usual activities 5.3 23.9 13.1 10.5 2 ,0.0001 4.8 4.4
pain and discomfort 8.8 40.9 19.3 21.3 3.3 ,0.0001 9.2 7.4
anxiety and depression 7.6 29 15.5 12.8 4 ,0.0001 6.4 5.8
EQ VAS
Mean(SE) 80(0.7) 65.3 (1.7) 71.6 (0.8) 76.7 (1.4) 82.7 (0.7) ,0.0001 79.8 (2) 77.6 (2)
Group 1: People with chronic conditions and had experienced discomfort during the two weeks immediately before the survey;
Group 2: People with chronic conditions but did not experience any discomfort during the two weeks immediately before the survey;
Group 3: People without chronic conditions and experienced discomfort during the two weeks immediately before the survey;
Group 4: People without chronic condition but did not experience any discomfort during the two weeks immediately before the survey.
P value: chi-square test whether there is any difference among any of the four groups.
NHSS 2008: National Health Service Survey conducted in 2008 in China. We recalculated the EQ-5D and EQ VAS of the overall population and western population
according to the results reported by Sun S [23].
doi:10.1371/journal.pone.0065958.t003
Table 4. Proportions of reporting any problem in EQ-5D and
EQ VAS among patients with one or more chronic conditions.
Total Number of chronic condition
one two
three or
more P-value
EQ-5D
mobility 18.9 16.7 26.2 36.5 0.003*
self-care 12.8 11.4 18.2 20.6 0.037*
usual activities 18.4 16.5 24.8 34.9 0.007*
pain and
discomfort
30 27.7 39.5 41.3 0.032*
anxiety and
depression
22.1 21 25.2 34.9 0.019*
EQ VAS
Mean(SE) 68.5 (1.1) 69.5 (1.2) 64.7 (2.2) 63.7 (3.2) ,0.001**
*: chi-square test whether there is any difference among any of the three
chronic groups with different number of chronic condition;
**: ANOVA test; SE: standard error.
doi:10.1371/journal.pone.0065958.t004
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chronic conditions. This may be one of the most pressing
challenges in the prevention and control of chronic diseases. We
suggest that the focus of a national chronic disease prevention and
control strategy should encompass the young population as well in
order to reduce the eventual impact on health.
The MOH has stated that the township hospitals and
community health care centers are responsible for the manage-
ment of hypertension, type 2 diabetes mellitus, and severe mental
diseases. It has also established many national chronic disease
prevention and control experimental areas across the country
[14,43,44]. It will be necessary to include the EQ-5D in the
indicator framework for surveillance and evaluation of these areas
to increase the cost-effectiveness of intervention programs. We did
not choose weights from Japan or Hong Kong to calculate the EQ-
Table 5. Risk of non-chronic problems among respondents with specific chronic diseases.
Disease OR (95% CI)
mobility self-care usual activities pain and discomfort anxiety and depression
Infectious disease
OR I 4.1 (1.0–16.4) 3.7 (0.4–30.9) 4.7 (1.1–19.2) * 7.1 (2.8–17.8) ** 5.9 (2.0–17.0) **
OR II 0.9 (0.2–3.7) 0.6 (0.0–6.0) 0.9 (0.2–3.6) 1.1 (0.4–2.9) 1.8 (0.5–5.8)
Cancer
OR I 12.7 (4.6–35.2) ** 18.4 (6.5–52.0) ** 14.5 (5.9–35.8) ** 14.1 (7.0–28.5) ** 10.2 (5.8–18.0) **
OR II 2.8 (1.0–7.7) 3.4 (1.2–9.5) * 2.8 (1.1–6.7) * 2.2 (1.1–4.3) 3.2 (2.0–5.0) **
Diabetes
OR I 5.3 (2.8–9.9) ** 5.6 (2.4–12.9) ** 8.1 (4.7–14.2) ** 7.1 (4.1–12.2) ** 4.8 (2.6–9.1) **
OR II 1.1 (0.6–2.1) 1.0 (0.5–2.0) 1.5 (0.9–2.7) 1.1 (0.6–1.9) 1.5 (0.9–2.5)
Anemia
OR I 4.8 (1.6–13.7) ** - 2.7 (0.7–9.8) 8.3 (4.5–15.3) ** 8.3 (4.4–15.5) **
OR II 1.0 (0.3–3.2) - 0.5 (0.1–1.8) 1.3 (0.7–2.2) 2.6 (1.3–5.2) **
Mental disease
OR I 9.9 (4.9–20.3) ** 27.1 (13.7–53.6) ** 28.6 (16.3–50.0) ** 16.1 (9.1–28.7) ** 16.3 (10.8–24.6) **
OR II 2.2 (1.0–4.6) * 5.0 (2.4–10.6) ** 5.4 (3.0–9.9) ** 2.5 (1.4–4.5) ** 5.1 (3.0–8.5) **
Heart disease
OR I 10.8 (7.3–16.0) ** 11.5 (6.5–20.6) ** 11.1 (7.1–17.3) ** 10.1 (7.0–14.6) ** 7.3 (4.8–11.1) **
OR II 2.4 (1.7–3.4) ** 2.1 (1.2–3.7) * 2.1 (1.3–3.3) ** 1.5 (1.0–2.4) * 2.3 (1.4–3.7) **
Hypertension
OR I 6.8 (5.0–9.2) ** 7.7 (4.7–12.5) ** 6.7 (4.7–9.6) ** 6.2 (4.6–8.3) ** 3.7 (2.7–5.2) **
OR II 1.5 (1.0–2.1) * 1.4 (0.9–2.0) 1.3 (0.8–1.9) 0.9 (0.6–1.3) 1.1 (0.8–1.6)
Cerebrovascular disease
OR I 28.3 (20.7–38.6) ** 42.2 (28.1–63.6) ** 31.1 (22.3–43.5) ** 19.2(14.5–25.6)** 11.8 (8.7–16.0) **
OR II 6.3 (4.6–8.5) ** 7.8 (5.3–11.4) ** 5.9 (4.0–8.9) ** 3.0 (2.1–4.2) ** 3.7 (2.7–5.0) **
Respiratory disease
OR I 6.8 (4.0–11.7) ** 9.8 (5.2–18.2) ** 8.6 (4.9–15.0) ** 8.5 (5.1–14.0) ** 5.4 (2.9–10.0) **
OR II 1.5 (0.8–2.7) 1.8 (0.9–3.4) 1.6 (0.8–3.1) 1.3 (0.8–1.9) 1.6 (0.9–3.0)
Digestive disease
OR I 2.7 (1.4–5.0) ** 4.9 (2.4–10.0) ** 4.4 (2.0–9.5) ** 7.0 (4.0–12.1) ** 3.1 (1.8–5.4) **
OR II 0.6 (0.2–1.3) 0.9 (0.3–2.2) 0.8 (0.3–2.1) 1.0 (0.6–1.8) 0.9 (0.6–1.6)
Genitourinary disease
OR I 9.0 (5.1–16.1) ** 7.6 (3.4–16.9) ** 7.2 (3.4–14.9) ** 7.2 (3.6–14.4) ** 4.4 (2.5–7.6) **
OR II 2.0 (1.0–3.9) * 1.4 (0.6–2.9) 1.3 (0.6–3.0) 1.1 (0.5–2.2) 1.3 (0.7–2.4)
Musculoskeletal disease
OR I 9.5 (6.3–14.3) ** 8.7 (4.7–16.4) ** 8.8 (5.4–14.5) ** 11.1 (7.7–15.8) ** 5.4 (3.4–8.3) **
OR II 2.1 (1.5–2.9) ** 1.6 (0.9–2.6) 1.7 (1.0–2.7) * 1.7 (1.3–2.2) ** 1.6 (1.1–2.5) *
Other chronic disease
OR I 7.0 (5.2–9.3) ** 10.4 (7.2–15.0) ** 9.1 (6.6–12.6) ** 9.8 (7.2–13.4) ** 5.9 (4.7–7.6) **
OR II 1.5 (1.0–2.2) * 1.9 (1.2–2.9) ** 1.7 (1.1–2.6) * 1.5 (1.1–2.0) ** 1.8 (1.4–2.4) **
Note: OR I = odds ratio of respondents with the selected chronic diseases relative to reference group I as defined in Table 1; OR II = odds ratio of respondents with the
selected chronic diseases relative to reference group II as defined in Table 1; *: chi-square test P,0.05; **: chi-square test P,0.01; No marks: not significant.
doi:10.1371/journal.pone.0065958.t005
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Table 6. Results of multivariate linear regression models.
Indicator Model I
a Model IIb
bc SEd P value bc SEd P value
Chronic diseases (against people with no chronic diseases at all)
Infectious disease 29.41 1.66 0.0004 - - -
Cancer 213.73 5.2 0.0351 - - -
Diabetes 25.86 1.28 ,.0001 - - -
Anemia 24.08 2.51 0.1144 - - -
Mental disease 228.03 3.58 ,.0001 - - -
Heart disease 210.7 1.9 ,.0001 - - -
Hypertension 24.69 0.87 ,.0001 - - -
Cerebrovascular disease 217.83 1.93 ,.0001 - - -
Respiratory disease 24.93 2.02 0.0210 - - -
Digestive disease 24.54 1.28 0.0013 - - -
Genitourinary disease 27.17 1.93 0.0008 - - -
Musculoskeletal disease 25.9 0.95 ,.0001 - - -
Other chronic disease 29.07 1.21 ,.0001 - - -
Co-morbidity (against healthy population)
No CD but health problems experienced during the two weeks
before the survey
- - - 0.66 1.71 0.7027
One CD - - - 26.52 0.77 ,.0001
Two CDs - - - 29.89 1.72 ,.0001
Three or more CDs - - - 210.58 3.1 0.0018
Socio-demographic characteristics
Urban area of residence 0.84 1.65 0.0254 0.90 1.68 0.0325
Male 0.84 0.35 0.0226 0.81 0.34 0.0244
High school education or more 1.08 0.39 0.0097 1.02 0.39 0.0146
Discomfort experienced during the two weeks
immediately before the survey
24.89 0.86 ,.0001 25.22 1.59 0.0027
Age (against 65+)
15–44 10.82 0.93 ,.0001 10.87 0.9 ,.0001
45–64 5.65 0.79 ,.0001 5.75 0.77 ,.0001
Marital status (against those currently married)
Divorced 21.01 1.29 0.4362 21.06 1.31 0.42
Widowed 21.61 0.77 0.0457 21.58 0.738 0.0394
Never married 2.49 0.61 0.0003 2.42 0.61 ,.0001
Other 1.83 1.43 0.2096 1.7 1.42 0.2399
Employment (against employed)
Retired 0.19 1.08 0.8601 0.31 1.1 0.7785
Unemployed 21.83 1.55 0.0248 21.98 1.55 ,.0001
Student 0.01 0.72 0.9927 0.07 0.71 0.9276
Social medical insurance (against those with no social medical insurance)
Urban workers’ medical insurance 21.77 0.99 0.0842 21.75 1.01 0.0935
Free medical service 2.82 3.08 0.0167 2.79 2.95 0.0097
Urban residents’ medical insurance 20.17 1.14 0.8808 20.15 1.16 0.8959
New rural cooperative medical system 20.52 1.46 0.7217 20.54 1.51 0.7207
Other 0.55 1.55 0.7238 0.46 1.54 0.7691
Smoker (against lifelong nonsmokers)
Smoker 20.77 0.48 0.1197 0.85 0.47 0.0790
Ex-smoker 22.21 1.37 0.1170 21.59 1.25 0.2150
Alcohol use (against those who have never drunk alcohol)
One or two times a week 20.92 1.22 0.4545 21.01 0.84 0.2386
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5D index though these populations are from Asia, because the
reliability and validity has not been demonstrated in a large-scale
Mainland Chinese population. Standards for the calculation of
EQ-5D index for Chinese populations must be developed before it
can be used in a wide or in-depth scale.
This is the largest population-based survey of chronic diseases
on HRQoL ever conducted in this region. The random multi-
stage stratified cluster sampling method was used to ensure sample
representativeness. HRQoL was measured using instruments that
are widely used throughout the world. Results established an
HRQoL baseline for the overall population and the chronically
diseased population in Shaanxi Province. We have found that the
main determinants of HRQoL include chronic conditions, co-
morbidity, age, employment status, education level, marital status,
area and location of residence, medical insurance, and level of
physical activity. This indicates that improvements in HRQoL will
involve consideration from medical professionals, policy makers,
society, and the individual. Through the comparison of the effects
experienced by those with different chronic conditions, we
identified cerebrovascular disease, cancer, and mental disease as
the three leading chronic conditions associated with low HRQoL
scores. Some limitations must be addressed here. The data were
derived from a cross-sectional survey, so the temporal sequence of
chronic conditions and changes in HRQoL must be assessed in
further studies using a longitudinal design. Another limitation was
that EQ-5D scores were replaced with EQ VAS scores, which may
be affected by participants’ mental status at the time of
measurement due to the absence of calculation standards.
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